Functional analysis of a de novo GRIN2A missense mutation associated with early-onset epileptic encephalopathy

被引:0
|
作者
Hongjie Yuan
Kasper B. Hansen
Jing Zhang
Tyler Mark Pierson
Thomas C. Markello
Karin V. Fuentes Fajardo
Conisha M. Holloman
Gretchen Golas
David R. Adams
Cornelius F. Boerkoel
William A. Gahl
Stephen F. Traynelis
机构
[1] Emory University School of Medicine,Department of Pharmacology
[2] Rollins Research Center,Departments of Pediatrics and Neurology
[3] and the Regenerative Medicine Institute,undefined
[4] Cedars-Sinai Medical Center,undefined
[5] NIH Undiagnosed Diseases Program,undefined
[6] Common Fund,undefined
[7] Office of the Director,undefined
[8] National Institutes of Health,undefined
[9] and National Human Genome Research Institute,undefined
[10] National Institutes of Health,undefined
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
NMDA receptors (NMDARs), ligand-gated ion channels, play important roles in various neurological disorders, including epilepsy. Here we show the functional analysis of a de novo missense mutation (L812M) in a gene encoding NMDAR subunit GluN2A (GRIN2A). The mutation, identified in a patient with early-onset epileptic encephalopathy and profound developmental delay, is located in the linker region between the ligand-binding and transmembrane domains. Electrophysiological recordings revealed that the mutation enhances agonist potency, decreases sensitivity to negative modulators including magnesium, protons and zinc, prolongs the synaptic response time course and increases single-channel open probability. The functional changes of this amino acid apply to all other NMDAR subunits, suggesting an important role of this residue on the function of NMDARs. Taken together, these data suggest that the L812M mutation causes overactivation of NMDARs and drives neuronal hyperexcitability. We hypothesize that this mechanism underlies the patient’s epileptic phenotype as well as cerebral atrophy.
引用
收藏
相关论文
共 50 条
  • [31] Children with Early-Onset Psychosis Have Increased Burden of Rare GRIN2A Variants
    Hojlo, Margaret A. A.
    Ghebrelul, Merhawi
    Genetti, Casie A. A.
    Smith, Richard
    Rockowitz, Shira
    Deaso, Emma
    Beggs, Alan H. H.
    Agrawal, Pankaj B. B.
    Glahn, David C. C.
    Gonzalez-Heydrich, Joseph
    Brownstein, Catherine A. A.
    GENES, 2023, 14 (04)
  • [32] A novel de novo heterozygous variant of the KCNQ2 gene: Contribution to early-onset epileptic encephalopathy in a female infant
    Liu, Hai-Feng
    Yuan, Ting-Yun
    Yang, Jia-Wu
    Li, Feng
    Wang, Fan
    Fu, Hong-Min
    MOLECULAR MEDICINE REPORTS, 2022, 26 (03)
  • [33] A case of early onset epileptic encephalopathy with de novo mutation in SLC35A2: Clinical features and treatment for epilepsy
    Kimizu, Tomokazu
    Takahashi, Yukitoshi
    Oboshi, Taikan
    Horino, Asako
    Koike, Takayoshi
    Yoshitomi, Shinsaku
    Mori, Tatsuo
    Yamaguchi, Tokito
    Ikeda, Hiroko
    Okamoto, Nobuhiko
    Nakashima, Mitsuko
    Saitsu, Hirotomo
    Kato, Mitsuhiro
    Matsumoto, Naomichi
    Imai, Katsumi
    BRAIN & DEVELOPMENT, 2017, 39 (03): : 256 - 260
  • [34] Identification and functional analysis of a novel de novo missense mutation located in the initiation codon of LAMP2 associated with early onset female Danon disease
    Wang, Yongxiang
    Bai, Ming
    Zhang, Piyi
    Peng, Yu
    Chen, Zixian
    He, Zhiyu
    Xu, Jin
    Zhu, Youqi
    Yan, Dongdong
    Wang, Runqing
    Zhang, Zheng
    MOLECULAR GENETICS & GENOMIC MEDICINE, 2023, 11 (09):
  • [35] De Novo Mutations in SLC35A2 Encoding a UDP-Galactose Transporter Cause Early-Onset Epileptic Encephalopathy
    Kodera, Hirofumi
    Nakamura, Kazuyuki
    Osaka, Hitoshi
    Maegaki, Yoshihiro
    Haginoya, Kazuhiro
    Mizumoto, Shuji
    Kato, Mitsuhiro
    Okamoto, Nobuhiko
    Iai, Mizue
    Kondo, Yukiko
    Nishiyama, Kiyomi
    Tsurusaki, Yoshinori
    Nakashima, Mitsuko
    Miyake, Noriko
    Hayasaka, Kiyoshi
    Sugahara, Kazuyuki
    Yuasa, Isao
    Wada, Yoshinao
    Matsumoto, Naomichi
    Saitsu, Hirotomo
    HUMAN MUTATION, 2013, 34 (12) : 1708 - 1714
  • [36] The therapeutic implication of a novel SCN2A mutation associated early-onset epileptic encephalopathy with Rett-like features
    Liang, Jao-Shwann
    Lin, Li-Ju
    Yang, Ming-Tao
    Wang, Jinn-Shyan
    Lu, Jyh-Feng
    BRAIN & DEVELOPMENT, 2017, 39 (10): : 877 - 881
  • [37] A Novel SCN2A Mutation In Neonate Presented With Lidocaine Responsive Early-Onset Epileptic Encephalopathy
    Padungmaneesub, W.
    Khongkhatithum, C.
    Thampratankul, L.
    Visudtibhan, A.
    Tim-Aroon, T.
    EPILEPSIA, 2019, 60 : 89 - 89
  • [38] A novel PIGA mutation in a family with X-linked, early-onset epileptic encephalopathy
    Kim, Young Ok
    Yang, Jae Hyuk
    Park, Chungoo
    Kim, Seul Kee
    Kim, Myeong-Kyu
    Shin, Myung-Geun
    Woo, Young Jong
    BRAIN & DEVELOPMENT, 2016, 38 (08): : 750 - 754
  • [39] GABRB1-related early onset developmental and epileptic encephalopathy: Clinical trajectory and novel de novo mutation
    Monfrini, Edoardo
    Borellini, Linda
    Zirone, Eleonora
    Yahya, Vidal
    Mauri, Eleonora
    Molisso, Maria Takeko
    Mameli, Francesca
    Ruggiero, Fabiana
    Comi, Giacomo Pietro
    Barbieri, Sergio
    Di Fonzo, Alessio
    Dilena, Robertino
    EPILEPTIC DISORDERS, 2023, 25 (06) : 867 - 873
  • [40] Phospholipase C beta 1 deficiency is associated with early-onset epileptic encephalopathy
    Kurian, Manju A.
    Meyer, Esther
    Vassallo, Grace
    Morgan, Neil V.
    Prakash, Nandhini
    Pasha, Shanaz
    Hai, Nebula A.
    Shuib, Salwati
    Rahman, Fatima
    Wassmer, Evangeline
    Cross, J. Helen
    O'Callaghan, Finbar J.
    Osborne, John P.
    Scheffer, Ingrid E.
    Gissen, Paul
    Maher, Eamonn R.
    BRAIN, 2010, 133 : 2964 - 2970